SMS2 siRNA inhibits pancreatic tumor growth by tumor microenvironment modulation

Xin Jiang1, Ziqing Yuan2, Tingbo Ding2

  • 1Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, China.

PubMed

Insights

Targeting sphingomyelin synthase 2 (SMS2) with siRNA gene therapy can reduce immune cell infiltration in pancreatic cancer. This approach suppresses tumor growth and improves the tumor microenvironment for potential pancreatic cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) exhibits significant treatment resistance due to suppressor immune cell infiltration in the tumor microenvironment (TME).
  • Sphingomyelin synthase 2 (SMS2) plays a key role in sphingolipid metabolism and plasma membrane integrity.

Purpose of the Study:

  • To develop and evaluate a self-assembling SMS2 siRNA gene expression plasmid for in vivo delivery.
  • To investigate the therapeutic potential of SMS2 inhibition in a pancreatic cancer model.

Main Methods:

  • Development of a self-assembling plasmid encoding SMS2 siRNA for targeted gene silencing.
  • In vivo administration of SMS2 siRNA in a murine Panc02 pancreatic carcinoma model.
  • Analysis of tumor growth, immune cell polarization (TAMs), immune cell infiltration (TANs), and associated signaling pathways (NF-κB/CXCL5).

Main Results:

  • SMS2 siRNA specifically inhibited SMS2 expression while sparing SMS1.
  • Administration of SMS2 siRNA suppressed tumor growth in the murine model.
  • SMS2 siRNA modulated tumor-associated macrophage polarization and reduced tumor-associated neutrophil infiltration.
  • The NF-κB/CXCL5 pathway was implicated in the observed immunomodulatory effects.

Conclusions:

  • Targeting SMS2 with siRNA represents a viable strategy to overcome treatment resistance in pancreatic cancer.
  • Modulating the immunosuppressive TME via SMS2 inhibition holds promise for pancreatic cancer therapy.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K